123 related articles for article (PubMed ID: 24078447)
1. ASAP3 expression in non-small cell lung cancer: association with cancer development and patients' clinical outcome.
Fan C; Tian Y; Miao Y; Lin X; Zhang X; Jiang G; Luan L; Wang E
Tumour Biol; 2014 Feb; 35(2):1489-94. PubMed ID: 24078447
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-143-3p inhibits colorectal cancer metastases by targeting ITGA6 and ASAP3.
Guo L; Fu J; Sun S; Zhu M; Zhang L; Niu H; Chen Z; Zhang Y; Guo L; Wang S
Cancer Sci; 2019 Feb; 110(2):805-816. PubMed ID: 30536996
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of ASAP3 contributes to colorectal carcinogenesis and indicates poor survival outcome.
Tian H; Qian J; Ai L; Li Y; Su W; Kong XM; Xu J; Fang JY
Cancer Sci; 2017 Aug; 108(8):1544-1555. PubMed ID: 28502111
[TBL] [Abstract][Full Text] [Related]
4. Reduced expression of liver kinase B1 and Beclin1 is associated with the poor survival of patients with non-small cell lung cancer.
Jiang L; Liang X; Liu M; Wang W; Ma J; Guo Q; Han L; Yang C; Nan K
Oncol Rep; 2014 Nov; 32(5):1931-8. PubMed ID: 25175672
[TBL] [Abstract][Full Text] [Related]
5. ASAP3 is a focal adhesion-associated Arf GAP that functions in cell migration and invasion.
Ha VL; Bharti S; Inoue H; Vass WC; Campa F; Nie Z; de Gramont A; Ward Y; Randazzo PA
J Biol Chem; 2008 May; 283(22):14915-26. PubMed ID: 18400762
[TBL] [Abstract][Full Text] [Related]
6. ASAP3 is a downstream target of HIF-1α and is critical for progression of lung adenocarcinoma.
Zhang P; Sun J; Kai J; Peng Y; Liu X; Zhou F; Wu J
Onco Targets Ther; 2019; 12():5793-5803. PubMed ID: 31410024
[No Abstract] [Full Text] [Related]
7. Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer.
Wang J; Tian X; Han R; Zhang X; Wang X; Shen H; Xue L; Liu Y; Yan X; Shen J; Mannoor K; Deepak J; Donahue JM; Stass SA; Xing L; Jiang F
Oncogene; 2014 Feb; 33(9):1181-9. PubMed ID: 23474761
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA ciRS-7 correlates with advance disease and poor prognosis, and its down-regulation inhibits cells proliferation while induces cells apoptosis in non-small cell lung cancer.
Yan B; Zhang W; Mao XW; Jiang LY
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8712-8721. PubMed ID: 30575911
[TBL] [Abstract][Full Text] [Related]
10. Increased stathmin correlates with advanced stage and poor survival of non-small cell lung cancer.
Rong B; Nan Y; Liu H; Gao W
Cancer Biomark; 2017; 19(1):35-43. PubMed ID: 28282798
[TBL] [Abstract][Full Text] [Related]
11. HOXA5 indicates poor prognosis and suppresses cell proliferation by regulating p21 expression in non small cell lung cancer.
Zhang ML; Nie FQ; Sun M; Xia R; Xie M; Lu KH; Li W
Tumour Biol; 2015 May; 36(5):3521-31. PubMed ID: 25549794
[TBL] [Abstract][Full Text] [Related]
12. The expression and function of miRNA-451 in non-small cell lung cancer.
Wang XC; Tian LL; Jiang XY; Wang YY; Li DG; She Y; Chang JH; Meng AM
Cancer Lett; 2011 Dec; 311(2):203-9. PubMed ID: 21875770
[TBL] [Abstract][Full Text] [Related]
13. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
[TBL] [Abstract][Full Text] [Related]
14. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.
Tang R; Zhong T; Dang Y; Zhang X; Li P; Chen G
Clin Transl Oncol; 2016 Apr; 18(4):360-8. PubMed ID: 26307752
[TBL] [Abstract][Full Text] [Related]
15. Detection of Brk expression in non-small cell lung cancer: clinicopathological relevance.
Fan C; Zhao Y; Liu D; Zhang X; Wang E
Tumour Biol; 2011 Oct; 32(5):873-80. PubMed ID: 21603980
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer.
Kong FF; Qu ZQ; Yuan HH; Wang JY; Zhao M; Guo YH; Shi J; Gong XD; Zhu YL; Liu F; Zhang WY; Jiang B
Oncol Rep; 2014 Jun; 31(6):2660-8. PubMed ID: 24715097
[TBL] [Abstract][Full Text] [Related]
17. KIAA0247 inhibits growth, migration, invasion of non-small-cell lung cancer through regulating the Notch pathway.
Xu Y; Ren H; Jiang J; Wang Q; Wudu M; Zhang Q; Su H; Wang C; Jiang L; Qiu X
Cancer Sci; 2018 Apr; 109(4):1055-1065. PubMed ID: 29451718
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Frat1 correlates with malignant phenotype and advanced stage in human non-small cell lung cancer.
Zhang Y; Yu JH; Lin XY; Miao Y; Han Y; Fan CF; Dong XJ; Dai SD; Wang EH
Virchows Arch; 2011 Sep; 459(3):255-63. PubMed ID: 21818639
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-510 Plays Oncogenic Roles in Non-Small Cell Lung Cancer by Directly Targeting SRC Kinase Signaling Inhibitor 1.
Wu W; He L; Huang Y; Hou L; Zhang W; Zhang L; Wu C
Oncol Res; 2019 Aug; 27(8):879-887. PubMed ID: 30982489
[TBL] [Abstract][Full Text] [Related]
20. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
Yang H; Gao XY; Li P; Jiang TS
Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
